Predicting for Lost to Follow-up in Surgical Management of Patients with Chronic Subdural Hematoma.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
04 2021
Historique:
received: 14 09 2020
revised: 24 12 2020
accepted: 26 12 2020
pubmed: 8 1 2021
medline: 28 7 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

Lost to follow-up (LTF) represents an understudied barrier to effective management of chronic subdural hematoma (cSDH). Understanding the factors associated with LTF after surgical treatment of cSDH could uncover pathways for quality improvement efforts and modify discharge planning. We sought to identify the demographic and clinical factors associated with patient LTF. A single-institution, retrospective cohort study of patients treated surgically for convexity cSDH from 2009 to 2019 was conducted. The primary outcome was LTF, with neurosurgical readmission as the secondary outcome. Univariate analysis was conducted using the student-t test and χ A total of 139 patients were included, 29% of whom were LTF. The mean first postoperative follow-up duration was 60 days. On univariate analysis, uninsured/Medicaid coverage was associated with increased LTF compared with private insurance/Medicare coverage (62.5% vs. 41.4%; P = 0.039). A higher discharge modified Rankin scale score was also associated with LTF (3.7 vs. 3.5; P < 0.001). On multivariate analysis, uninsured/Medicaid patients had a significantly greater risk of LTF compared with private insurance/Medicare patients (odds ratio, 2.44; 95% confidence interval, 1.13-5.23; P = 0.022). LTF was independently associated with an increased risk of neurosurgical readmission (odds ratio, 1.94; 95% confidence interval, 1.17-3.24; P = 0.011). Uninsured and Medicaid patients had a greater likelihood of LTF compared with private insurance and Medicare patients. LTF was further associated with an increased risk of neurosurgical readmission. The results from the present study emphasize the need to address barriers to follow-up to reduce readmission after surgery for cSDH. These findings could inform improved discharge planning, such as predischarge repeat imaging studies and postdischarge contact.

Sections du résumé

BACKGROUND
Lost to follow-up (LTF) represents an understudied barrier to effective management of chronic subdural hematoma (cSDH). Understanding the factors associated with LTF after surgical treatment of cSDH could uncover pathways for quality improvement efforts and modify discharge planning. We sought to identify the demographic and clinical factors associated with patient LTF.
METHODS
A single-institution, retrospective cohort study of patients treated surgically for convexity cSDH from 2009 to 2019 was conducted. The primary outcome was LTF, with neurosurgical readmission as the secondary outcome. Univariate analysis was conducted using the student-t test and χ
RESULTS
A total of 139 patients were included, 29% of whom were LTF. The mean first postoperative follow-up duration was 60 days. On univariate analysis, uninsured/Medicaid coverage was associated with increased LTF compared with private insurance/Medicare coverage (62.5% vs. 41.4%; P = 0.039). A higher discharge modified Rankin scale score was also associated with LTF (3.7 vs. 3.5; P < 0.001). On multivariate analysis, uninsured/Medicaid patients had a significantly greater risk of LTF compared with private insurance/Medicare patients (odds ratio, 2.44; 95% confidence interval, 1.13-5.23; P = 0.022). LTF was independently associated with an increased risk of neurosurgical readmission (odds ratio, 1.94; 95% confidence interval, 1.17-3.24; P = 0.011).
CONCLUSIONS
Uninsured and Medicaid patients had a greater likelihood of LTF compared with private insurance and Medicare patients. LTF was further associated with an increased risk of neurosurgical readmission. The results from the present study emphasize the need to address barriers to follow-up to reduce readmission after surgery for cSDH. These findings could inform improved discharge planning, such as predischarge repeat imaging studies and postdischarge contact.

Identifiants

pubmed: 33412320
pii: S1878-8750(20)32695-4
doi: 10.1016/j.wneu.2020.12.128
pmc: PMC8054037
mid: NIHMS1690062
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e294-e300

Subventions

Organisme : NCI NIH HHS
ID : T32 CA106183
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Neurosurg Clin N Am. 2017 Apr;28(2):205-210
pubmed: 28325454
World Neurosurg. 2018 Oct;118:e87-e91
pubmed: 29945004
J Clin Epidemiol. 1994 Aug;47(8):903-9
pubmed: 7730894
Clin Neurosurg. 2010;57:112-22
pubmed: 21280503
Health Serv Res. 2018 Dec;53(6):4682-4703
pubmed: 29766499
Surgery. 2014 Oct;156(4):949-56
pubmed: 25239351
Clin Spine Surg. 2018 Feb;31(1):E25-E29
pubmed: 27906738
J Trauma Acute Care Surg. 2014 Jan;76(1):185-90
pubmed: 24368377
Ann Fam Med. 2015 Mar;13(2):115-22
pubmed: 25755032
J Neurol Surg B Skull Base. 2016 Jun;77(3):226-30
pubmed: 27175317
Plast Reconstr Surg Glob Open. 2018 Sep 14;6(9):e1910
pubmed: 30349785
Spine (Phila Pa 1976). 2015 Dec;40(24):1934-40
pubmed: 26595443
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
Asian J Neurosurg. 2016 Oct-Dec;11(4):330-342
pubmed: 27695533
BMC Health Serv Res. 2015 May 12;15:195
pubmed: 25962725
Health Serv Res. 2012 Apr;47(2):614-32
pubmed: 22091980
Spine J. 2019 Oct;19(10):1672-1679
pubmed: 31125698
J Clin Neurosci. 2018 Apr;50:7-15
pubmed: 29428263
Acad Emerg Med. 2019 Feb;26(2):129-139
pubmed: 30648780
Circulation. 2013 Sep 10;128(11):1206-13
pubmed: 23946265
Med Care. 2017 Apr;55(4):428-435
pubmed: 27820594
BMC Ophthalmol. 2008 May 31;8:9
pubmed: 18513438
QJM. 2017 Jun 1;110(6):375-378
pubmed: 28069915
Am J Emerg Med. 2013 Oct;31(10):1495-500
pubmed: 24035046
Asian J Neurosurg. 2018 Oct-Dec;13(4):976-983
pubmed: 30459852
World Neurosurg. 2019 Dec;132:e506-e513
pubmed: 31450003
World Neurosurg. 2016 Mar;87:529-30
pubmed: 26407927
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Milbank Q. 2009 Jun;87(2):443-94
pubmed: 19523125
J Neurosurg. 2018 Nov 1;129(5):1143-1150
pubmed: 29243977

Auteurs

Alan R Tang (AR)

Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Electronic address: alan.r.tang@vanderbilt.edu.

Matthews Lan (M)

Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Katherine A Kelly (KA)

Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Bradley S Guidry (BS)

Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Aaron M Yengo-Kahn (AM)

Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Patrick D Kelly (PD)

Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Silky Chotai (S)

Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Peter J Morone (PJ)

Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH